Canada Journal – News of the World Articles and videos to bring you the biggest Canadian news stories from across the country every day
Patients with mild to moderate Alzheimer’s disease were able to care for themselves longer and needed less help performing everyday chores when they took a daily capsule containing 200 IUs of alpha tocopherol, or vitamin E, a study has found.
Compared with subjects who took placebo pills, those who took daily supplements of the antioxidant vitamin E and were followed for an average of two years, three months delayed their loss of function by a little more than six months on average, a 19 percent improvement. And the vitamin E group’s increased need for caregiver help was the lowest of several groups, including those taking the Alzheimer’s drug memantine, those taking memantine and vitamin E, and those taking a placebo pill.
“A delay in six months over two years, that’s very meaningful to some patients and caregivers,” Dysken, a professor of psychiatry at the University of Minnesota, said in a Dec. 27 telephone interview.
Dysken, who is a former director of the Geriatric Research, Education and Clinical Center at the Minneapolis VA Health Care System, added that his study “does not address whether vitamin E will prevent Alzheimer’s disease in people who don’t have the diagnosis.”
The study looked at 613 veterans who were given vitamin E, a combination of vitamin E and Forest Laboratories’s Namenda for moderate to severe Alzheimer’s, Namenda alone or a placebo. The vitamin E used in the study was about 20 times the dosage usually found in a multivitamin.
All patients in the trial were on some type of Alzheimer’s medication, such as Eisai’s Aricept or Johnson & Johnson’s Razadyne. The main outcome was how well patients could perform activities of daily living.
They found that vitamin E slowed the worsening of the disease by 19 percent a year compared with placebo. The research also showed those who took care of patients taking vitamin E were able to spend less time caregiving than for those taking Namenda alone.
Canadajournal/AP
